Skip to content

KADUWZJENYYSQJ-VEIFNGETSA-N

C42H45Cl2F3N6O6S2 — CID 159075180

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC2-(4-chlorophenyl)-N-ethyl-2-[4-(methanesulfonamido)indol-1-yl]butanamide;(2R)-2-(4-chlorophenyl)-2-[4-(methanesulfonamido)indol-1-yl]-N-(2,2,2-trifluoroethyl)butanamide
SMILESCCNC(=O)C(CC)(c1ccc(Cl)cc1)n1ccc2c(NS(C)(=O)=O)cccc21.CC[C@](C(=O)NCC(F)(F)F)(c1ccc(Cl)cc1)n1ccc2c(NS(C)(=O)=O)cccc21
InChIInChI=1S/C21H21ClF3N3O3S.C21H24ClN3O3S/c1-3-20(14-7-9-15(22)10-8-14,19(29)26-13-21(23,24)25)28-12-11-16-17(27-32(2,30)31)5-4-6-18(16)28;1-4-21(20(26)23-5-2,15-9-11-16(22)12-10-15)25-14-13-17-18(24-29(3,27)28)7-6-8-19(17)25/h4-12,27H,3,13H2,1-2H3,(H,26,29);6-14,24H,4-5H2,1-3H3,(H,23,26)/t20-;/m1./s1
InChIKeyKADUWZJENYYSQJ-VEIFNGETSA-N
MW921.89 g/mol
LogP8.45
Rot. Bonds14

About KADUWZJENYYSQJ-VEIFNGETSA-N

KADUWZJENYYSQJ-VEIFNGETSA-N (PubChem CID 159075180) has the molecular formula C42H45Cl2F3N6O6S2 and a molecular weight of 921.89 g/mol. Its IUPAC name is 2-(4-chlorophenyl)-N-ethyl-2-[4-(methanesulfonamido)indol-1-yl]butanamide;(2R)-2-(4-chlorophenyl)-2-[4-(methanesulfonamido)indol-1-yl]-N-(2,2,2-trifluoroethyl)butanamide.

Molecular Properties

Compound NameKADUWZJENYYSQJ-VEIFNGETSA-N
PubChem CID159075180
Molecular FormulaC42H45Cl2F3N6O6S2
Molecular Weight921.89 g/mol
Exact Mass920.22
IUPAC Name2-(4-chlorophenyl)-N-ethyl-2-[4-(methanesulfonamido)indol-1-yl]butanamide;(2R)-2-(4-chlorophenyl)-2-[4-(methanesulfonamido)indol-1-yl]-N-(2,2,2-trifluoroethyl)butanamide
SMILESCCNC(=O)C(CC)(c1ccc(Cl)cc1)n1ccc2c(NS(C)(=O)=O)cccc21.CC[C@](C(=O)NCC(F)(F)F)(c1ccc(Cl)cc1)n1ccc2c(NS(C)(=O)=O)cccc21
InChIInChI=1S/C21H21ClF3N3O3S.C21H24ClN3O3S/c1-3-20(14-7-9-15(22)10-8-14,19(29)26-13-21(23,24)25)28-12-11-16-17(27-32(2,30)31)5-4-6-18(16)28;1-4-21(20(26)23-5-2,15-9-11-16(22)12-10-15)25-14-13-17-18(24-29(3,27)28)7-6-8-19(17)25/h4-12,27H,3,13H2,1-2H3,(H,26,29);6-14,24H,4-5H2,1-3H3,(H,23,26)/t20-;/m1./s1
InChIKeyKADUWZJENYYSQJ-VEIFNGETSA-N
XLogP8.45
TPSA160.40 Ų
H-Bond Donors4
H-Bond Acceptors8
Rotatable Bonds14
Heavy Atoms61
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500921.89
LogP ≤ 58.45
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 108

Analyze KADUWZJENYYSQJ-VEIFNGETSA-N with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of KADUWZJENYYSQJ-VEIFNGETSA-N?
The IUPAC name of KADUWZJENYYSQJ-VEIFNGETSA-N (CID 159075180) is 2-(4-chlorophenyl)-N-ethyl-2-[4-(methanesulfonamido)indol-1-yl]butanamide;(2R)-2-(4-chlorophenyl)-2-[4-(methanesulfonamido)indol-1-yl]-N-(2,2,2-trifluoroethyl)butanamide.
What is the SMILES notation for KADUWZJENYYSQJ-VEIFNGETSA-N?
The canonical SMILES for KADUWZJENYYSQJ-VEIFNGETSA-N is CCNC(=O)C(CC)(c1ccc(Cl)cc1)n1ccc2c(NS(C)(=O)=O)cccc21.CC[C@](C(=O)NCC(F)(F)F)(c1ccc(Cl)cc1)n1ccc2c(NS(C)(=O)=O)cccc21.
What is the InChIKey of KADUWZJENYYSQJ-VEIFNGETSA-N?
The InChIKey is KADUWZJENYYSQJ-VEIFNGETSA-N. The full InChI is InChI=1S/C21H21ClF3N3O3S.C21H24ClN3O3S/c1-3-20(14-7-9-15(22)10-8-14,19(29)26-13-21(23,24)25)28-12-11-16-17(27-32(2,30)31)5-4-6-18(16)28;1-4-21(20(26)23-5-2,15-9-11-16(22)12-10-15)25-14-13-17-18(24-29(3,27)28)7-6-8-19(17)25/h4-12,27H,3,13H2,1-2H3,(H,26,29);6-14,24H,4-5H2,1-3H3,(H,23,26)/t20-;/m1./s1.
What are the key properties of KADUWZJENYYSQJ-VEIFNGETSA-N?
KADUWZJENYYSQJ-VEIFNGETSA-N has a molecular weight of 921.89 g/mol, XLogP of 8.45, 14 rotatable bonds, 4 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for KADUWZJENYYSQJ-VEIFNGETSA-N is sourced from PubChem (CID 159075180), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.